<DOC>
	<DOCNO>NCT00549263</DOCNO>
	<brief_summary>This study test whether Drug level plasma combination formulation tablet dosing ( SB797620 ) separate formulation tablet dose ( rosiglitazone glimepiride ) Japanese Healthy volunteer would .</brief_summary>
	<brief_title>Bioequivalence Study SB797620 Healthy Japanese Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy subject They Japanese male . Aged 20 55 year , inclusive . They body mass index screen within 18.525.0 . Body weight 5080kg . AST ( GOT ) , ALT ( GPT ) , gummaGPT ALP : upper normal range They capable give write informed consent , include compliance requirement restriction list consent form . They could refrain smoke hospitalization . They able attend visit complete study . The subject clinically relevant abnormality medical examination , vital sign , clinical laboratory test medical history screen medical opinion investigator subject medical history consider eligible inclusion study investigator . Known hepatic biliary abnormality Gilbert 's syndrome . Use insulin oral antihyperglycemic agent within past 3 month prior screen . Subjects history lactose intolerance . The subject allergy drug idiosyncrasy . This exclude pollen allergy without current symptom . The subject currently participate another clinical study postmarketing study subject expose investigational noninvestigational drug device . The subject participate clinical study investigational noninvestigational drug device previous 4 month . The subject screening ECG QTc value outside range 320 450msec , PR interval &gt; 230msec and/or QRS interval &gt; 120msec . The subject heart rate outside range 40 110 bpm screening . The subject donate unit blood `` &gt; 400mL '' within previous 4 month `` &gt; 200mL '' within previous 1 month . The subject currently take regular ( course ) medication ( include prescribe drug , overthecounter medication herbal remedy ) , cease 30 day prior th first study drug dosing . The subject history current condition drug abuse alcoholism . History alcohol consumption past six month exceed 7 drink per week ( 1 drink 350mL term beer ) The subject positive syphilis , HBs antigen , HCV antibody , HIV antigen/antibody , HTLV1 antibody . The subject positive urine drug screening . Current history hypo hyperglycemia indicate serum glucose value laboratoryspecified reference range =110 mg/dL , screening , report subject . History surgical procedure might affect absorption RSG GLIM ( e.g. , partial/total gastrectomy , cholecystectomy ) . History hypersensitivity thiazolidinediones , sulfonylureas compound similar chemical structure . History sensitivity heparin , heparininduced thrombocytopenia sensitivity study medication component thereof .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Safety</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Bioequivalence</keyword>
</DOC>